
TNDM Stock Forecast & Price Target
TNDM Analyst Ratings
Bulls say
Tandem Diabetes Care is a strong investment candidate due to its strong performance and growth drivers, as well as its focus on sustainability and expansion into new markets. However, challenges with supplier shortages and market conditions may impact stock performance in the short term. The company's differentiation from competitors and potential for profitability growth make it an attractive long-term investment option.
Bears say
Tandem Diabetes Care is a technology company with a strong potential for consistent double-digit revenue growth due to its innovative insulin pump designs and upcoming product pipeline, however, there are potential downside risks such as slower-than-expected market expansion and competitive threats that may limit its ability to take market share. Additionally, dependence on third-party suppliers and lack of reimbursement from payers could impact Tandem's growth and profitability, and there is a risk of product recalls. Despite these risks, the company's current fundamental setup and upcoming OUS renewal cycle make it an attractive investment opportunity, with room for multiple expansions and potential for a re-rating of 1-1.5x turns above its median 1.7x target. It is important to monitor the company's execution over the next few years to determine if it can meet growth and profitability targets.
This aggregate rating is based on analysts' research of Tandem Diabetes Care and is not a guaranteed prediction by Public.com or investment advice.
TNDM Analyst Forecast & Price Prediction
Start investing in TNDM
Order type
Buy in
Order amount
Est. shares
0 shares